Efficacy and Safety of Chiglitazar Added to Glargine in Patients With Type 2 Diabetes

Clinical trial NCT06007014 · UNKNOWN

Trial details

NCT number: NCT06007014
Sponsor: Yanbing Li
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Efficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM Patients Metformin Combined With Insulin Glargine in the Treatment of Type 2 Diabetes Patients Who Still Have Poor Hypoglycemic Effect 128 Patients Were Randomly Assigned 1:1 Metformin and Insulin Glargine Combined With Chiglitazar Sodium Tablets 48mg/ Day Group Metformin and Insulin Glargine Combined With Placebo Group InvestigatorInitiate Trial Changes in HbA1C From Baseline at 18 Weeks of Treatment

Start date: 2023-10-31
Primary completion: 2025-10-30
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.